Interim analysis of an interferon (INF)-and ribavirin (RBV)-free regimen of daclatasvir (DCV), asunaprevir (ASV), and BMS-791325 in treatment-naive, hepatitis C virus genotype 1-infected patients

The requested reference [d7fac657387abba5a39700c739136277d33904f3] no longer exists in our database. It has been replaced by the current reference: [5095d2b9a9f7141a2d10b644142ce70dca0e5290]

Authors
Category Primary study
ConferenceJournal of Gastroenterology and Hepatology
Year 2013
This article has no abstract
Epistemonikos ID: 2c05785fb10628420cc443dc7d693c2f64fda838
First added on: Apr 30, 2026